P2RY2 and pancreatic neoplasm: Here, we present a novel single-molecule based approach to study the oligomerization of a rhodopsin-like GPCR, the purinergic receptor Y2 (P2Y2), in a pancreatic cancer cell line with high expression of the receptor [19].